Human Bcl-2 antisense therapy for lymphomas

被引：46

作者：

Cotter, FE

Waters, J

Cunningham, D

机构：

[1] Inst Child Hlth, Div Canc Biol, Mol Haematol Unit, London WC1N 1EH, England

[2] Royal Marsden Hosp, Dept Med, Sutton, Surrey, England

来源：

BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 1999年 / 1489卷 / 01期

关键词：

antisense; Bcl-2; apoptosis; lymphoma; human trial;

D O I：

10.1016/S0167-4781(99)00139-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：97 / 106

页数：10

共 40 条

[1] PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J].

AGRAWAL, S ;

TEMSAMANI, J ;

TANG, JY .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7595-7599

[2]

BACON TA, 1991, ONCOGENE RES, V6, P13

[3] Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies [J].

Bishop, MR ;

Iversen, PL ;

Bayever, E ;

Sharp, JG ;

Greiner, TC ;

Copple, BL ;

Ruddon, R ;

Zon, G ;

Spinolo, J ;

Arneson, M ;

Armitage, JO ;

Kessinger, A .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1320-1326

[4]

Calabretta B, 1996, SEMIN ONCOL, V23, P78

[5]

COTTER FE, 1994, ONCOGENE, V9, P3049

[6]

COTTER FE, 1996, ANN ONCOL, V7, P32

[7]

DAAKA Y, 1990, ONCOGENE RES, V5, P267

[8]

Eder P S, 1991, Antisense Res Dev, V1, P141

[9]

*EUR ORG RES TREAT, 1994, PRACT GUID EORTC STU

[10] COMPLEMENT ACTIVATION AND HEMODYNAMIC-CHANGES FOLLOWING INTRAVENOUS ADMINISTRATION OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES IN THE MONKEY [J].

GALBRAITH, WM ;

HOBSON, WC ;

GICLAS, PC ;

SCHECHTER, PJ ;

AGRAWAL, S .

ANTISENSE RESEARCH AND DEVELOPMENT, 1994, 4 (03) :201-206

← 1 2 3 4 →